Fundz

Sengine Precision Medicine Closes Series A Bringing Total Financing To $19M Enabling Continued Advancement Of Personalized Cancer Treatments

PRIVATEJul 28, 2022

Round Type

Series A

SeattleBiotechnology

Description

Seattle-based Precision Oncology company SEngine Precision Medicine has now raised a total of $19M, following the recent closing of a $10M Series A2, as it continues to commercialize a platform that matches cancer patients to the right drug and also drives drug discovery.

Quick answer

SEngine Precision Medicine, Inc. raised an undisclosed amount in a Series A round, dated July 28, 2022. SEngine Precision Medicine, Inc. is based in Seattle, Washington, United States.

How much did SEngine Precision Medicine, Inc. raise?
SEngine Precision Medicine, Inc. raised an undisclosed amount in a Series A round on July 28, 2022.
What does SEngine Precision Medicine, Inc. do?
SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer.
Where is SEngine Precision Medicine, Inc. based and how big is it?
SEngine Precision Medicine, Inc. is based in Seattle, Washington, United States.
Who are the decision-makers at SEngine Precision Medicine, Inc?
Fundz holds 1 contact at SEngine Precision Medicine, Inc., including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SEngine Precision Medicine, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $2.1M (Seed) on September 9, 2022.
  • PRECIDIAG raised $3M (Seed) on September 9, 2022.
  • Novabay raised $5.3M (Post-IPO Equity) on September 9, 2022.
  • ABK Biomedical raised $18M on September 9, 2022.
  • Cardinal Morrisville Biotech raised $500K (Seed) on September 9, 2022.
  • Kuria Therapeutics raised an undisclosed amount (Funding Round) on September 8, 2022.

Who to call at SEngine Precision Medicine, Inc., and when

A new round usually means SEngine Precision Medicine, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SEngine Precision Medicine, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SEngine Precision Medicine, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SEngine Precision Medicine, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SEngine Precision Medicine, Inc.

Location

401 TERRY AVE N.

Seattle, Washington, United States

About

SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer. With a focus on functional screening, genomics, robotics, cancer organoid cultures, and bioinformatics, SEngine Precision Medicine is providing invaluable data to oncologists and realizing the promise of precise, less toxic and more effective therapies to cancer patients. The accumulation of data is essential to pharmaceutical companies to accelerate the success of cancer treatments. SEngine is CLIA certified to receive your sample today.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SEngine Precision Medicine, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCarla G., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SEngine Precision Medicine, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

SEngine Precision Medicine, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.